세계의 특수 효소 시장 : 규모, 점유율, 동향 분석(제품별, 용도별, 원료별, 지역별), 부문별 예측(2025-2030년)

Specialty Enzymes Market Growth & Trends:

The global specialty enzymes market size is expected to reach USD 8.89 billion by 2030, registering a CAGR of 6.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. This is attributable to the specific yield optimization and catalytic reaction properties of specialty enzymes.

Pharmaceutical manufacturers across the globe have incorporated these specialty enzymes on account of their expanding applications particularly in processing fine chemicals and pure pharmaceutical drugs. The shift in trend towards the adoption of specialty enzymes in order to reduce reliance on conventional enzymes has been observed in the last few years and hence these enzymes are expected to penetrate the overall industry growth. Specialty enzymes are widely used to manufacture drugs to treat some fatal diseases such as cardiovascular diseases, cancer, and pain caused by age, asthma, hay fever, and lysosomal storage disorders in the pharmaceutical industry. The increasing prevalence of such diseases coupled with the growing geriatric population particularly in the U.S., Europe, and Japan is also expected to have a positive influence on industry growth.

Growth of the global pharmaceutical industry, growing number of biotechnology R&D, and advancement in enzyme engineering & green chemistry are expected to fuel the market over the forecast period. Difficulty in maintaining pH and operational temperature of specialty enzymes is expected to remain a key concern for key players. Legal & ethical issues coupled to lack of awareness among consumers regarding the benefits of specialty enzymes particularly in developing countries is also expected to pose threat to the market growth. However, the growing industrialization rate and advanced technologies adopted in the pharmaceutical industry in emerging markets of BRIC nations is expected to hold future opportunities for industry participants.

North America emerged as the largest regional specialty enzyme market owing to the presence of niche consumers and advanced technologies. An increase in population and growth in disposable income among consumers in emerging markets of China and India is expected to drive the industry demand in the Asia Pacific region. China, India, and Brazil are expected to be the most lucrative regional markets for specialty enzymes. Some of the key specialty enzyme manufacturers include Advanced Enzyme Technology Ltd. Affymetrix Inc., Advanced Enzyme Technology Ltd., Amano Enzyme Inc., Bbi Enzymes Ltd., Basf, Codexis Inc., Nagase & Co. Ltd., Life Technologies, Roche Holding Ag., and Sanofi S.A among others.

Specialty Enzymes Market Report Highlights:

• The carbohydrase segment dominated the market with the largest revenue share of 37.6% in 2024, fueled by rising consumer demand for dietary supplements and digestive health products that rely heavily on carbohydrase enzymes. The proteases segment is anticipated to grow at a significant CAGR of 6.5% over the forecast period.
• The pharmaceutical segment held the largest revenue share in 2024, propelled by rising population, growing consumer demand, and increasing disease awareness. The biocatalyst segment is projected to be the fastest-growing segment in the specialty enzymes industry from 2025 to 2030.
• The microorganisms segment accounted for the largest market share in 2024 due to the widespread use of amylases in the biotechnology and pharmaceutical industries. The animal segment is projected to grow at the fastest CAGR over the forecast period.
• North America specialty enzymes market dominated the global market with the largest revenue share of 41.9% in 2024. The U.S. specialty enzymes market held the largest share in 2024, owing to increased demand for specialty enzymes in pharmaceuticals and diagnostics.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources & Third-Party Perspectives
  • 1.3.4. Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Data Visualization
• 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Specialty Enzymes Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related Market Outlook
• 3.2. Industry Value Chain Analysis
• 3.3. Regulatory Framework
• 3.4. Market Dynamics
  • 3.4.1. Market Driver Analysis
  • 3.4.2. Market Restraint Analysis
  • 3.4.3. Industry Challenges
  • 3.4.4. Industry Opportunities
• 3.5. Industry Analysis Tools
  • 3.5.1. Porter's Five Forces Analysis
  • 3.5.2. Macro-environmental Analysis

Chapter 4. Specialty Enzymes Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. Specialty Enzymes Market: Product Movement Analysis & Market Share, 2024 & 2030
• 4.3. Carbohydrase
  • 4.3.1. Carbohydrase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Proteases
  • 4.4.1. Proteases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Lipases
  • 4.5.1. Lipases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Polymerases & Nucleases
  • 4.6.1. Polymerases & Nucleases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Others
  • 4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Specialty Enzymes Market: Application Estimates & Trend Analysis

• 5.1. Application Segment Dashboard
• 5.2. Specialty Enzymes Market: Application Movement Analysis & Market Share, 2024 & 2030
• 5.3. Pharmaceutical
  • 5.3.1. Pharmaceutical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Research & Biotechnology
  • 5.4.1. Research & Biotechnology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Diagnostics
  • 5.5.1. Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Biocatalyst
  • 5.6.1. Biocatalyst Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Specialty Enzymes Market: Source Estimates & Trend Analysis

• 6.1. Source Segment Dashboard
• 6.2. Specialty Enzymes Market: Source Movement Analysis & Market Share, 2024 & 2030
• 6.3. Plants
  • 6.3.1. Plants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Animals
  • 6.4.1. Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Microorganisms
  • 6.5.1. Microorganisms Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Specialty Enzymes Market: Regional Estimates & Trend Analysis

• 7.1. Regional Movement Analysis & Market Share, 2024 & 2030
• 7.2. North America
  • 7.2.1. North America Specialty Enzymes Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.2.2. U.S.
    • 7.2.2.1. Key Country Dynamics
    • 7.2.2.2. U.S. Specialty Enzymes Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.2.3. Canada
    • 7.2.3.1. Key Country Dynamics
    • 7.2.3.2. Canada Specialty Enzymes Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.2.4. Mexico
    • 7.2.4.1. Key Country Dynamics
    • 7.2.4.2. Mexico Specialty Enzymes Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• 7.3. Europe
  • 7.3.1. Europe Specialty Enzymes Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. U.K.
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. U.K. Specialty Enzymes Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Germany
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Germany Specialty Enzymes Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.3.4. France
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. France Specialty Enzymes Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.3.5. Spain
    • 7.3.5.1. Key Country Dynamics
    • 7.3.5.2. Spain Specialty Enzymes Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.3.6. Italy
    • 7.3.6.1. Key Country Dynamics
    • 7.3.6.2. Italy Specialty Enzymes Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• 7.4. Asia Pacific
  • 7.4.1. Asia Pacific Specialty Enzymes Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. China
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. China Specialty Enzymes Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Japan
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Japan Specialty Enzymes Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. India
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. India Specialty Enzymes Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.4.5. South Korea
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. South Korea Specialty Enzymes Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.4.6. Indonesia
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Indonesia Specialty Enzymes Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.4.7. Australia
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Australia Specialty Enzymes Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• 7.5. Latin America
  • 7.5.1. Latin America Specialty Enzymes Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. Brazil
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Brazil Specialty Enzymes Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Argentina
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Argentina Specialty Enzymes Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• 7.6. Middle East & Africa
  • 7.6.1. Middle East & Africa Specialty Enzymes Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Saudi Arabia
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Saudi Arabia Specialty Enzymes Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. Turkiye
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Turkiye Specialty Enzymes Market Estimates & Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Specialty Enzymes Market - Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Heat Map
• 8.4. Position Analysis, 2024
• 8.5. Strategy Mapping
  • 8.5.1. Expansion
  • 8.5.2. Mergers & Acquisition
  • 8.5.3. Partnerships & Collaborations
  • 8.5.4. New Product Launches
  • 8.5.5. Research and Development
• 8.6. Company Profiles
  • 8.6.1. Advanced Enzyme Technologies
    • 8.6.1.1. Participant's Overview
    • 8.6.1.2. Financial Performance
    • 8.6.1.3. Product Benchmarking
    • 8.6.1.4. Recent Developments
  • 8.6.2. Affymetrix Inc. (Thermo Fisher Scientific Inc.)
    • 8.6.2.1. Participant's Overview
    • 8.6.2.2. Financial Performance
    • 8.6.2.3. Product Benchmarking
    • 8.6.2.4. Recent Developments
  • 8.6.3. Amano Enzyme Inc.
    • 8.6.3.1. Participant's Overview
    • 8.6.3.2. Financial Performance
    • 8.6.3.3. Product Benchmarking
    • 8.6.3.4. Recent Developments
  • 8.6.4. BBI Solutions
    • 8.6.4.1. Participant's Overview
    • 8.6.4.2. Financial Performance
    • 8.6.4.3. Product Benchmarking
    • 8.6.4.4. Recent Developments
  • 8.6.5. BASF
    • 8.6.5.1. Participant's Overview
    • 8.6.5.2. Financial Performance
    • 8.6.5.3. Product Benchmarking
    • 8.6.5.4. Recent Developments
  • 8.6.6. Codexis, Inc.
    • 8.6.6.1. Participant's Overview
    • 8.6.6.2. Financial Performance
    • 8.6.6.3. Product Benchmarking
    • 8.6.6.4. Recent Developments
  • 8.6.7. Nagase & Co., Ltd.
    • 8.6.7.1. Participant's Overview
    • 8.6.7.2. Financial Performance
    • 8.6.7.3. Product Benchmarking
    • 8.6.7.4. Recent Developments
  • 8.6.8. Life Technologies (Thermo Fisher Scientific Inc.)
    • 8.6.8.1. Participant's Overview
    • 8.6.8.2. Financial Performance
    • 8.6.8.3. Product Benchmarking
    • 8.6.8.4. Recent Developments
  • 8.6.9. F. Hoffmann-La Roche Ltd
    • 8.6.9.1. Participant's Overview
    • 8.6.9.2. Financial Performance
    • 8.6.9.3. Product Benchmarking
    • 8.6.9.4. Recent Developments
  • 8.6.10. Sanofi
    • 8.6.10.1. Participant's Overview
    • 8.6.10.2. Financial Performance
    • 8.6.10.3. Product Benchmarking
    • 8.6.10.4. Recent Developments